Re: The first report on coronavirus disease 2019 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey: Consideration of recent findings on COVID-19 vaccine adherence in cancer patients
- PMID: 34649763
- PMCID: PMC8463312
- DOI: 10.1016/j.ejca.2021.07.048
Re: The first report on coronavirus disease 2019 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey: Consideration of recent findings on COVID-19 vaccine adherence in cancer patients
Conflict of interest statement
Conflict of interest statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Luigi Cavanna: Consulting or Advisory Role for AstraZeneca; Travel, Accommodations, Expenses from Pfizer, Ipsen and Celgene. Other authors: No Relationships to Disclose.
Comment on
-
The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.Eur J Cancer. 2021 Aug;153:260-264. doi: 10.1016/j.ejca.2021.05.006. Epub 2021 May 26. Eur J Cancer. 2021. PMID: 34183225 Free PMC article.
References
-
- Di Noia V., Renna D., Barberi V., Di Civita M., Riva F., Costantini G., et al. The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey. Eur J Cancer. 2021;153:260–264. doi: 10.1016/j.ejca.2021.05.006. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical